Search term:
2010 / 02
PHARMAC documents that matched your search:
2010-03 Clinicians Newsletter
(2 pages, 62 KB)
2010/02/26
Pharmaceutical Management Agency PHO Newsletter Aromatase inhibitors There are some changes to the subsidises for aromatase inhibitors. In summary: March 2010 Anastrozole • Both DP-Anastrozole and Arimidex brands will remain fully funded from 1 February 2010. Arimidex remains fully funded…
February Tender Notification
(2 pages, 62 KB)
2010/02/26
26 February 2010 TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products included in the Invitation to Tender dated 21…
Proposal to amend Growth Hormone access criteria. Closed
(2 pages, 150 KB)
2010/02/24
24 February 2010 Proposal to Amend Growth Hormone Access Criteria PHARMAC is seeking feedback on a proposal to make several amendments to the Growth Hormone Access Criteria. In summary, this proposal would result in: § a revision of the cut-off…
Proposal to widen access to gemcitabine hydrochloride and vinorelbine. Closed
(4 pages, 172 KB)
2010/02/19
19 February 2010 Proposal to widen access to gemcitabine hydrochloride and vinorelbine PHARMAC is seeking feedback on a proposal to widen funded access to gemcitabine hydrochloride. In summary, the proposal involves: § § Widening access to subsidised gemcitabine and vinorelbine…
Schedule Update - effective 1 March 2010
(50 pages, 657 KB)
2010/02/18
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 March 2010 Cumulative for January, February and March 2010 Section H cumulative for December 2009, January, February and March 2010 Contents Summary of PHARMAC decisions effective 1 March 2010 …..…
Aromatase Inhibitor brand change
(4 pages, 192 KB)
2010/02/17
Aromatase inhibitors – patient information Recently PHARMAC has made decisions that mean there are changes to the subsidies for some aromatase inhibitors. Aromatase inhibitors are a type of medicine used to treat breast cancer. PHARMAC currently funds three different types…
Proposal to fund lignocaine urethral syringes. Closed
(1 page, 103 KB)
2010/02/17
17 February 2010 Proposal to fund lignocaine urethral syringes PHARMAC is seeking feedback on a proposal to list lignocaine gel 2% (10 ml urethral syringe) in Section B and in Part II of Section H of the Pharmaceutical Schedule from…
Cost-Utility Analysis (CUA) Explained
(12 pages, 504 KB)
2010/02/15
Pharmaceutical Management Agency Cost-Utility Analysis (CUA) Explained Cost-Utility Analysis (CUA) at PHARMAC Questions and Answers go to page 8 >> The process described in this document is intended to be indicative of the process that PHARMAC may use when undertaking…
Proposal to fund bisacodyl suppositories (Dulcolax). Closed
(1 page, 105 KB)
2010/02/15
15 February 2010 Proposal to fund bisacodyl suppositories (Dulcolax) PHARMAC is seeking feedback on a proposal to fund a new brand of bisacodyl 10 mg suppositories (Dulcolax) and fully fund the 5 mg strength (Dulcolax) on the Pharmaceutical Schedule. This…
Proposal to reference price risperidone. Closed
(3 pages, 154 KB)
2010/02/15
15 February 2010 Proposal to apply reference pricing across different brands of risperidone PHARMAC is seeking feedback on a proposal to apply reference pricing across different brands of risperidone from 1 June 2010, where such reference pricing is possible in…
Search tips
Search or Browse
To search for a document enter a search term into the search form and activate the Search button.
Documents may be browsed by date, eg; Today, May, 2012.
Past years can be browsed too...
2011, 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003, 2002, 2001, 2000, 1999, 1998, 1997, 1996, 1995, 1994.
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg;
Media releases from 2012
Search terms
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Document tags (shown in bolded red below document date) have highest priority when search results are ranked, followed by title, abstract and full text of document (if available). Tags in use include...
AnnualReview, archive, BoardPaper, BusinessPlan, CAC, CACminutes, CCNotifications, ClinNewsletter, consultation, EC, EOI, etender, herceptin, inpharmation, leaflet, LetterOfExpectations, media, notification, NPPA, OIA, OutputAgreement, PatientGuide, policy, PTAC, PTACminutes, PTACSCMinutes, Q&A, release, resource, RFI, RFP, SAForm, SAForms, schedule, ScheduleDispatch, SchedulePublications, SectionH, SOI, TdrNotification, tender, update, vacancy, WhatsNew.
Documents with related dates can be browsed through the date component links below the document title.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
